International Overdose Awareness Day marks 25 years, spotlighting fragile declines in deaths and urging naloxone access, harm reduction funding, and stigma-free care.
|Videos|August 17, 2022
Substance Use Disorder: A Brain Disease
Author(s)Brian Hurley, MD, MBA, DFASAM
Medication, counseling, and support—just as important in substance use disorder treatment as any other brain disease.
Advertisement
Brian Hurley, MD, MBA, DFASAM, gives a summary on his talk on medication treatment and psychotherapy for substance use disorders from the
Dr Hurley is the Medical Director of the Substance Abuse Prevention and Control at the Los Angeles County Department of Public Health.
Advertisement
Related to this article
Axsome launches SUMMIT phase 3 testing AXS-05 to help adults quit smoking, comparing it with bupropion and placebo over 12 weeks.
Review news in psychiatry from the last week.
Advertisement
Advertisement
Trending on Psychiatric Times
1
Vol 43, Issue 9 - Interactive
2
FDA Hearing on Psychedelic Medicine Reveals a Field Divided on the Road to Approval
3
Insights on the New Adult ADHD Guidelines: A Conversation With the President of APSARD
4
New Adult ADHD Guidelines: What Resources Are Coming Soon
5